PPA
FENC icon

Parametric Portfolio Associates’s Fennec Pharmaceuticals FENC Stock Holding History

Parametric Portfolio Associates’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,994
Closed -$104K – 3660
2021
Q3 		$104K Sell
10,994
-11,441
-51% -$85.8K ﹤0.01% 3530
2021
Q2 		$164K Sell
22,435
-5,069
-18% -$33.8K ﹤0.01% 3433
2021
Q1 		$171K Sell
27,504
-53
-0.2% -$399 ﹤0.01% 3907
2020
Q4 		$205K Buy
27,557
+3,395
+14% +$25.9K ﹤0.01% 3764
2020
Q3 		$146K Buy
24,162
+9,934
+70% +$70K ﹤0.01% 3730
2020
Q2 		$119K Buy
+14,228
New +$106K ﹤0.01% 3745
2019
Q2 		– Sell
-42,165
Closed -$205K – 3968
2019
Q1 		$205K Buy
42,165
+10,538
+33% +$69.3K ﹤0.01% 3715
2018
Q4 		$202K Buy
+31,627
New +$221K ﹤0.01% 3661

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Parametric Portfolio Associates's FENC Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of Fennec Pharmaceuticals (FENC) in Q4 2021, closing a stake of 10,994 shares — an estimated $104K sold.

Parametric Portfolio Associates first reported a position in FENC in Q4 2018 and held it in 8 quarters. The position peaked at $205K in Q4 2020. 30 funds tracked by Wall St. Rank hold FENC as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining Fennec Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 10,994 Fennec Pharmaceuticals shares in Q4 2021, an estimated $104K.
  • Parametric Portfolio Associates first reported a position in Fennec Pharmaceuticals in Q4 2018 and held it in 8 quarters.
  • Parametric Portfolio Associates's Fennec Pharmaceuticals position peaked at $205K in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.